Bullish on Pharma Sector: Vaibhav Sanghavi

  • 29:49
  • Published On: July 21, 2016
Cinema View
Embed
Vaibhav Sanghavi, managing director and fund manager at Ambit Investment Advisors, said that pharma stocks are trading at a discount to their historical valuations. Pharma companies' remedial action on regulatory issues is also positive, he added.

Related Videos

Sensex Gains Over 50 Points, Nifty Near 10,930
January 23, 2019 1:29
Markets Rebound After Tuesday's Selloff
July 19, 2017 1:58
Regulatory Environment Unfavourable For Pharma Companies: Surjit Pal
May 23, 2017 9:10
Still Cautious On Pharma Stocks: Hemen Kapadia
May 03, 2017 28:05
Prefer Pharma Stocks Over Tech: SV Prasad
April 17, 2017 41:20
Domestic Liquidity Strong: Avendus Capital
February 09, 2017 31:23
Sell Dr Reddy's Labs With Stop Loss At Rs 3,090: Manas Jaiswal
January 09, 2017 9:52
UK Approval For Seretide MDI: Cipla
December 27, 2016 7:20
Sell Aurobindo Pharma For Target Of Rs 600: Sumeet Bagadia
December 20, 2016 13:45
Invest For Long Term Via SIPs: Chintan Haria
December 01, 2016 21:03
Accumulate Sun Pharma At Current Levels: Sumeet Bagadia
November 08, 2016 13:23
Bearish On Large Cap Pharma Stocks: Surjit Pal
November 04, 2016 4:17
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination